Thursday, March 10, 2011

Exclusive: Accuray, TomoTherapy chiefs explain merger


>>But in conversation with DOTmed News, both Accuray CEO and President Euan S. Thomson and TomoTherapy CEO Dr. Frederick A. Robertson have hopes the transaction will have an "emergent" property greater than the sum of its parts.

Both men argue the combined companies will streamline overhead expenses and also combine technological know-how to make TomoTherapy's previously struggling service business break even by the end of the year. They also see benefit to what they're viewing as a melding of Silicon Valley marketing and Madison's engineering strengths.

No comments: